Ignite Creation Date:
2024-05-06 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 12:49 PM
Study NCT ID:
NCT03597282
Status:
TERMINATED
Last Update Posted:
2020-09-03
First Post:
2018-07-13
Brief Title:
A Personal Cancer Vaccine NEO-PV-01 and APX005M or Ipilimumab With Nivolumab in Patients With Advanced Melanoma
Sponsor:
BioNTech US Inc
Organization:
BioNTech SE
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-10-08
Start Date Type:
ACTUAL
Primary Completion Date:
2020-05-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-08-11
Completion Date Type:
ACTUAL
First Submit Date:
2018-07-13
First Submit QC Date:
July 13 2018
Study First Post Date:
2018-07-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-01
Last Update Post Date:
2020-09-03
Last Update Post Date Type:
ACTUAL